DSIP 5mg

Description

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide that has been studied for its influence on various physiological processes within the central nervous system. In preclinical models, DSIP has been explored for its potential role in reducing oxidative stress and supporting cardiovascular function, including the regulation of myocardial contractility.

Ongoing research has also investigated DSIP as a possible target in studies related to mood regulation and neurochemical balance, particularly in the context of depressive-like behaviors in animal models.

This compound is provided strictly for laboratory research use only and is not intended for human or veterinary use.

Description

What is DSIP (Delta Sleep-Inducing Peptide)?

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring short peptide originally identified in the late 1970s during studies on sleep regulation in animal models. It was first isolated from rat brain tissue during periods of slow-wave (delta) sleep, which led to its name. Since then, DSIP has become the focus of research exploring its broader biological roles beyond sleep modulation.

Preclinical studies suggest that DSIP may influence several neuroendocrine and physiological processes, including the regulation of corticotropin levels, somatostatin inhibition, stress response, blood pressure normalization, pain modulation, and sleep architecture. Additional areas of research include its potential relevance in oxidative stress, mood regulation, and oncology models, although these findings remain early-stage and experimental.

DSIP is intended for laboratory research use only and is not approved for human or veterinary use.

DSIP – Research Overview

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide that has been studied in various animal models and in vitro systems for its potential role in neurological, endocrine, and physiological regulation.

Based on research studies, DSIP has been observed to:

• Influence sleep regulation, particularly by modulating slow-wave (delta) sleep patterns
• Affect corticotropin (ACTH) levels, which play a role in the body’s stress response
• Inhibit the secretion of somatostatin, a hormone that affects growth hormone release and other regulatory pathways
• Exhibit potential in reducing markers of oxidative stress in select models
• Help normalize blood pressure and promote homeostasis during stress conditions
• Modulate pain sensitivity and perception in certain animal studies

Additional exploratory research is evaluating DSIP’s role in mood regulation, neuroprotection, and its possible relevance in conditions involving inflammation and cellular stress. These findings are early-stage and remain confined to preclinical environments.

DSIP is provided strictly for laboratory research use only. It is not intended for human or veterinary use.